Mayukh Sukhatme

CIK: 0001750050

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (37.8%)

Position reduction

Option Exercises (M)18 (40.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)10 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROIV

Roivant Sciences Ltd.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (45 total)

ROIV
Roivant Sciences Ltd.
Oct 16, 2026
Tax Payment(F)
Direct
20K shares at avg. $33.53$670K
ROIV
Roivant Sciences Ltd.
Sep 30, 2026
Tax Payment(F)
Direct
46.9K shares at avg. $36.57$1.7M
ROIV
Roivant Sciences Ltd.
Aug 21, 2026
Sale(S)
Direct
144.8K shares at avg. $36.48$5.3M
ROIV
Roivant Sciences Ltd.
Aug 21, 2026
Exercise(M)
Direct
144.8K shares at avg. $3.85$557K
ROIV
Roivant Sciences Ltd.
Aug 20, 2026
Sale(S)
Direct
17.5K shares at avg. $37.30$653K
ROIV
Roivant Sciences Ltd.
Aug 20, 2026
Exercise(M)
Direct
17.5K shares at avg. $3.85$67K
ROIV
Roivant Sciences Ltd.
Aug 19, 2026
Sale(S)
Direct
172.9K shares at avg. $37.17$6.4M
ROIV
Roivant Sciences Ltd.
Aug 19, 2026
Exercise(M)
Direct
172.9K shares at avg. $3.85$666K
ROIV
Roivant Sciences Ltd.
Aug 18, 2026
Sale(S)
Direct
31.8K shares at avg. $37.18$1.2M
ROIV
Roivant Sciences Ltd.
Aug 18, 2026
Exercise(M)
Direct
31.8K shares at avg. $3.85$122K
ROIV
Roivant Sciences Ltd.
Aug 18, 2026
Sale(S)
Direct
105.1K shares at avg. $36.59$3.8M
ROIV
Roivant Sciences Ltd.
Aug 18, 2026
Exercise(M)
Direct
105.1K shares at avg. $3.85$405K
ROIV
Roivant Sciences Ltd.
Aug 17, 2026
Sale(S)
Direct
284.7K shares at avg. $36.25$10.3M
ROIV
Roivant Sciences Ltd.
Aug 17, 2026
Exercise(M)
Direct
284.7K shares at avg. $3.85$1.1M
ROIV
Roivant Sciences Ltd.
Aug 14, 2026
Sale(S)
Direct
243.2K shares at avg. $36.23$8.8M
ROIV
Roivant Sciences Ltd.
Aug 14, 2026
Exercise(M)
Direct
243.2K shares at avg. $3.85$936K
ROIV
Roivant Sciences Ltd.
Jun 30, 2026
Tax Payment(F)
Direct
46.9K shares at avg. $35.39$1.7M
ROIV
Roivant Sciences Ltd.
Jun 26, 2026
Exercise(M)
Direct
500K shares at avg. $3.85$1.9M
ROIV
Roivant Sciences Ltd.
Jun 26, 2026
Sale(S)
Direct
500K shares at avg. $34.08$17.0M
ROIV
Roivant Sciences Ltd.
Jun 25, 2026
Sale(S)
Direct
500K shares at avg. $34.13$17.1M
ROIV
Roivant Sciences Ltd.
Jun 25, 2026
Exercise(M)
Direct
500K shares at avg. $3.85$1.9M
ROIV
Roivant Sciences Ltd.
Mar 31, 2026
Tax Payment(F)
Direct
187.5K shares at avg. $27.70$5.2M
ROIV
Roivant Sciences Ltd.
Mar 30, 2026
Tax Payment(F)
Direct
29.8K shares at avg. $26.41$787K
ROIV
Roivant Sciences Ltd.
Mar 30, 2026
Exercise(M)
Direct
58.4K shares-
ROIV
Roivant Sciences Ltd.
Feb 9, 2026
Other(J)
Direct
312.1K shares at avg. $26.47$8.3M

		Type	Shares	Price		Ownership
Oct 16, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	19,976	$33.53	$669,795	Direct
Sep 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	46,879	$36.57	$1,714,365	Direct
Aug 21, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	144,756	$36.48	$5,280,699	Direct
Aug 21, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	144,756	$3.85	$557,311	Direct
Aug 20, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	17,519	$37.30	$653,459	Direct
Aug 20, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	17,519	$3.85	$67,448	Direct
Aug 19, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	172,899	$37.17	$6,426,656	Direct
Aug 19, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	172,899	$3.85	$665,661	Direct
Aug 18, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	31,801	$37.18	$1,182,361	Direct
Aug 18, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	31,801	$3.85	$122,434	Direct
Aug 18, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	105,141	$36.59	$3,847,109	Direct
Aug 18, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	105,141	$3.85	$404,793	Direct
Aug 17, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	284,707	$36.25	$10,320,629	Direct
Aug 17, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	284,707	$3.85	$1,096,122	Direct
Aug 14, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	243,177	$36.23	$8,810,303	Direct
Aug 14, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	243,177	$3.85	$936,231	Direct
Jun 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	46,878	$35.39	$1,659,012	Direct
Jun 26, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	500,000	$3.85	$1,925,000	Direct
Jun 26, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	500,000	$34.08	$17,040,000	Direct
Jun 25, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	500,000	$34.13	$17,065,000	Direct
Jun 25, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	500,000	$3.85	$1,925,000	Direct
Mar 31, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	187,512	$27.70	$5,194,082	Direct
Mar 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	29,809	$26.41	$787,256	Direct
Mar 30, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	58,391	-	$0	Direct
Feb 9, 2026	ROIV Roivant Sciences Ltd.	Other(J)	312,117	$26.47	$8,261,737	Direct

1-25 of 45 transactions

About Sukhatme Mayukh

Sukhatme Mayukh (SEC CIK 0001750050) files insider reports with the SEC as President & CIO of Roivant Sciences Ltd. (ROIV).

Signal8 holds 13 ownership filings by Sukhatme Mayukh, all Form 4s, filed between Dec 5, 2024 and Oct 20, 2026. Those filings report 45 transactions, from Dec 3, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sukhatme Mayukh's filings is in LONDON.

Recent filings by Sukhatme Mayukh

Oct 16, 2026: Tax withholding of ROIV shares (Form 4, code F).
Sep 30, 2026: Tax withholding of ROIV shares (Form 4, code F).
Aug 21, 2026: Open-market sale of ROIV shares (Form 4, code S).
Aug 21, 2026: Option exercise of ROIV shares (Form 4, code M).
Aug 20, 2026: Open-market sale of ROIV shares (Form 4, code S).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
Epperly Melissa B,, Director
MOMTAZEE JAMES C, Director
Gline Matthew, CEO
Torti Frank, President and Vant Chair

How to read Form 4 transaction codes